Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.

Item

http://www.wikidata.org/entity/Q36350762

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@ast

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@en

type

Item

label

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@ast

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@en

prefLabel

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@ast

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@en

P1476

Quantitative analysis of estro ...... dy is more sensitive than 1D5.

@en

P2093

Allison W Welsh

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Hallie Wimberly

http://www.w3.org/2001/XMLSchema#string

Malini Harigopal

http://www.w3.org/2001/XMLSchema#string

Manju Prasad

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies.

Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.

Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Current issues in ER and HER2 testing by IHC in breast cancer.

P304

139-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAI.0B013E31825D73B2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22820659

http://www.w3.org/2001/XMLSchema#string

P932

3482297

http://www.w3.org/2001/XMLSchema#string